Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0640
D

Incorrect MDS Coding of Anticoagulant Use

La Verne, California Survey Completed on 04-04-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to accurately code the Minimum Data Set (MDS) for a resident regarding the use of anticoagulant medication. The resident, who had a history of hemiplegia, hemiparesis following a cerebral infarction, diabetes mellitus, and generalized muscle weakness, was admitted and had an order for Plavix (clopidogrel), an antiplatelet medication, to be administered daily for a cerebrovascular accident. The MDS, dated shortly after admission, incorrectly indicated that the resident received anticoagulant medication. During interviews and record reviews, it was clarified by the MDS Nurse that Plavix is classified as an antiplatelet, not an anticoagulant, and should not have been coded under the anticoagulant section (N0415E) of the MDS. The DON confirmed that accurate medication documentation on the MDS is essential for proper care planning and that anticoagulant and antiplatelet medications are coded separately due to their different mechanisms and uses. The CMS RAI User's Manual also specifies that antiplatelet medications should be coded distinctly from anticoagulants.

An unhandled error has occurred. Reload 🗙